SOURCE: Market Pulse

September 02, 2009 08:45 ET

Market Pulse Breaking News Alert for Wednesday, September 2, 2009: ARYC -- Arrayit Lands Patent for Population Scale Diagnostics in China and Expects China to Be a Diagnostics Business Bonanza!

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Market Pulse.

ATLANTA, GA--(Marketwire - September 2, 2009) - Arrayit Corporation (OTCBB: ARYC), a proprietary life science technology leader, announces the incorporation of Arrayit Diagnostics, Inc., a majority owned Nevada Corporation, to be headquartered in Houston, Texas. The company is currently developing several diagnostic tests for cancer, neurodegenerative disease, and other disease states. Arrayit Diagnostics will promote the commercialization of these tests using Arrayit's microarray platform. By conclusively identifying the genomic and proteomic biomarkers for specific diseases, these tests will allow early stage diagnosis leading to life saving and cost saving treatment protocols.

Arrayit Diagnostics is being put in position to launch one of the most intensive marketing campaigns in Arrayit's twelve year history. Supported by a massive network of 41 international life science and diagnostics distributors located in 38 countries, Arrayit will use this opportunity to expand its worldwide customer base of 10,000 research labs to become a significant global diagnostics company.

About Arrayit Corporation

Arrayit Corporation, headquartered in Sunnyvale, California, leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. It now offers over 650 products to a customer base of more than 2,500 laboratories worldwide, including most every major university, pharmaceutical and biotech company, major agricultural and chemical company, government agency, national research foundation and many private sector enterprises. Please visit for more information.

Stocks in the news and acting well as of late include: Avanir Pharmaceuticals (NASDAQ: AVNR), Jazz Pharmaceuticals Inc. (NASDAQ: JAZZ) and Brigham Exploration Co. (NASDAQ: BEXP).

Information contained herein is the opinion of ("MP") and is intended to be used strictly for informational purposes. You should be aware that MP attempts to assure itself of the accuracy of the information contained in the analyses it publishes. In this regard, MP does, at times, rely on the accuracy of information supplied to it by the companies which are the subject of MP's analyses and/or parties related to those companies. MP also relies on the accuracy and integrity of information that is contained in company press releases and reports filed with the SEC. The companies mentioned in this publication have not approved the content or timing of the information being published unless otherwise noted.

MP, because it relies on information supplied by various third parties disclaims any responsibility for the accuracy of such information. Any investor considering making an investment in any security which has been the subject of a MP analysis or opinion should, before making any such investment, consult with his/her market professional and/or do his/her own independent research regarding the company which is the subject of an MP opinion, recommendation or analysis. Information regarding companies which MP has opined upon is normally available from many sources including the subject company's filings with the SEC and various press releases issued by the company.

You should be aware that MP is often compensated for issuing analyses, recommendations or opinions concerning particular companies. Its opinion is therefore not unbiased and you should consider this factor when evaluating MP's statements regarding a company. MP has been compensated, in connection with its profile of Arrayit Corporation, fifty thousand shares of Arrayit Corporation's common stock by a third party shareholder. Additionally, MP bought for its own account in the open market, forty thousand shares of Arrayit Corporation's shares for a total purchase price of twenty three thousand eight hundred twenty dollars. To date, MP has not sold any of these shares. MP's officers and directors reserve the right to buy additional shares of the companies discussed in this opinion and may profit in the event those shares rise in value. When MP receives shares as compensation for a profiled company, MP may sell part or all of any such shares during the period in which MP is performing such services. and Market Pulse Breaking News Alert are owned by Market Pulse LLC.

Contact Information